Lipella Pharmaceuticals Stock Forecast

LIPO's stock price has decreased by -55.03% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Lipella Pharmaceuticals stock has a target of 16, which predicts an increase of 566.53% from the current stock price of 2.40.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$16	$16	$16	$16
Change	+566.53%	+566.53%	+566.53%	+566.53%

* Price targets were last updated on Apr 9, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Lipella Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Apr '24
Strong Buy	1
Buy	0
Hold	0
Sell	0
Strong Sell	0
Total	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Initiates $16	Strong Buy	Initiates	$16	+566.53%	Apr 9, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

370.26K

from 449.62K

-17.65%

from 449.62K

Revenue Next Year

n/a

from 370.26K

EPS This Year

-8.01

from -6.16

EPS Next Year

-5.30

from -8.01

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	694.75K	961.68K	259.35K	184.16K	449.62K	370.26K	-	-
Revenue Growth	-	38.42%	-73.03%	-28.99%	144.15%	-17.65%	-	-
EPS	-0.24	-0.23	-4.40	-5.12	-6.16	-8.01	-5.30	-17.77
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	381,150	n/a	n/a
Avg	370,260	n/a	n/a
Low	355,740	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	-15.2%	-	-
Avg	-17.6%	-	-
Low	-20.9%	-	-

EPS Forecast

EPS	2024	2025	2026
High	-8.24	-5.46	-18.29
Avg	-8.01	-5.30	-17.77
Low	-7.69	-5.10	-17.07

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.